FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges
Crossref DOI link: https://doi.org/10.1038/s44184-025-00174-2
Published Online: 2025-11-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herpertz, Julian
Stern, Ariel D.
Opel, Nils
Reininghaus, Ulrich
Torous, John
Text and Data Mining valid from 2025-11-26
Version of Record valid from 2025-11-26
Article History
Received: 24 March 2025
Accepted: 10 November 2025
First Online: 26 November 2025
Competing interests
: The authors declare no competing interests.